INFLARX NV's ticker is IFRX and the CUSIP is N44821101. A total of 39 filers reported holding INFLARX NV in Q2 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 732,670 | $27,688,000 | 11.07% |
| Cormorant Asset Management, LP | 2,590,000 | $97,876,000 | 6.62% |
| RA Capital Management | 2,810,708 | $106,217,000 | 4.58% |
| Redmile Group, LLC | 2,182,638 | $82,482,000 | 2.41% |
| EMORY UNIVERSITY | 71,884 | $2,716,000 | 1.91% |
| Artal Group S.A. | 825,000 | $31,177,000 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 175,414 | $6,629,000 | 0.89% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,500 | $1,223,000 | 0.45% |
| Birchview Capital, LP | 16,000 | $605,000 | 0.38% |
| Eventide Asset Management | 275,000 | $10,392,000 | 0.36% |